Shots: The EMA has validated the MAA for ARCT-154, a next-generation mRNA vaccine...
Shots: The EC has granted full marketing authorization for Nuvaxovid (NVX-CoV2373)...
Shots: The P-III trial (MOVe-AHEAD) evaluating Lagevrio (800mg) vs PBO in 1500 pat...
Shots: The company initiates the P-II trial, conducted in 2 parts evaluating the c...
Shots: The P-III trial results published in
Shots: The P-II study evaluating the immunogenicity & safety profile of recomb...